⌘K

Login Start Free

Home/Filings/4/0001209191-14-008713

4//SEC Filing

SALIX PHARMACEUTICALS LTD 4

Accession 0001209191-14-008713

CIK 0001009356operating

View on SEC.gov Company Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:50 PM ET

Size

9.4 KB

Accession

0001209191-14-008713

Insider Transaction Report

Form 4

Period: 2014-02-06

SALIX PHARMACEUTICALS LTDSLXP

CHAPPELL JOHN F

Director

Transactions

Exercise/Conversion
Option to Buy Common Stock
2014-02-06−22,500→ 0 total
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying)
Exercise/Conversion
Common Stock
2014-02-06$18.87/sh+22,500$424,649→ 470,834 total

Holdings

Common Stock
(indirect: By Spouse)
8,200
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying)
15,000
Common Stock
(indirect: By GRAT)
50,000

Footnotes (1)

[F1]Options are 100% vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001009356

Filing Metadata

Form type: 4
Filed: Feb 9, 7:00 PM ET
Accepted: Feb 10, 4:50 PM ET
Size: 9.4 KB

View on SEC.gov